Background Background The pharmacological
The pharmacological management of violence in people with management of violence in people with psychiatric disorders is under-researched. psychiatric disorders is under-researched.
Aims Aims To compare interventions
To compare interventions commonly used for controlling agitation or commonly used for controlling agitation or violence in people with serious psychiatric violence in people with serious psychiatric disorders. disorders.
Method Method We randomised 200 people to
Werandomised 200 peopleto receive intramuscular lorazepam (4 mg) receive intramuscular lorazepam (4 mg) or intramuscular haloperidol (10 mg) plus or intramuscular haloperidol (10 mg) plus promethazine (25^50 mg mix). promethazine (25^50 mg mix).
Results

Results At blinded assessments 4 h
At blinded assessments 4 h later (99.5% follow-up), equal numbers in later (99.5% follow-up), equal numbers in both groups (96%) were tranquil or both groups (96%) were tranquil or asleep.However, 76% given the asleep.However, 76% given the haloperidol^promethazine mix were haloperidol^promethazine mix were asleep compared with 45% of those asleep compared with 45% of those allocated lorazepam (RR allocated lorazepam (RR¼2.29,95% CI 2.29,95% CI 1.59^3.39;NNT 1.59^3.39;NNT¼3.2,95% CI 2.3^5.4).The 3.2,95% CI 2.3^5.4).The haloperidol^promethazine mix produced haloperidol^promethazine mix produced a faster onset of tranquillisation/sedation a faster onset of tranquillisation/sedation and more clinical improvement over the and more clinical improvement over the first 2 h.Neither intervention differed first 2 h.Neither intervention differed significantly in the need for additional significantly in the need for additional intervention or physical restraints, intervention or physical restraints, numbers absconding, or adverse effects. numbers absconding, or adverse effects.
Conclusions Conclusions Both interventions are
Both interventions are effective for controlling violent/agitated effective for controlling violent/agitated behaviour.If speed of sedation is required, behaviour.If speed of sedation is required, the haloperidol^promethazine the haloperidol^promethazine combination has advantages over combination has advantages over lorazepam. lorazepam.
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Violent or aggressive behaviour is a Violent or aggressive behaviour is a common reason for emergency psychiatric common reason for emergency psychiatric presentations, with assaultive behaviour presentations, with assaultive behaviour seen in 3-10% of psychiatric patients seen in 3-10% of psychiatric patients (Tardiff & Sweillam, 1982; Tardiff & (Tardiff & Sweillam, 1982; Tardiff & Koenigsberg, 1985) . A haloperidol- Koenigsberg, 1985) . A haloperidolpromethazine mix is commonly used for promethazine mix is commonly used for rapid tranquillisation of agitated or violent rapid tranquillisation of agitated or violent patients in India and Brazil (Huf patients in India and Brazil (Huf et al et al, , 2002 (Huf et al et al, , 2002a . Promethazine is an antihistamine ). Promethazine is an antihistamine that adds to the sedative effect of haloperithat adds to the sedative effect of haloperidol and prevents acute dystonic reactions dol and prevents acute dystonic reactions otherwise common with the intramuscular otherwise common with the intramuscular use of haloperidol (Van Harten use of haloperidol (Van Harten et al et al, , 1999) . As a haloperidol-promethazine 1999). As a haloperidol-promethazine mix had not been evaluated previously in mix had not been evaluated previously in the context of a randomised trial, two pragthe context of a randomised trial, two pragmatic trials were designed by the Tranquilimatic trials were designed by the Tranquilizaccao Rapida-Ensaio Clınic TREC zǎ cçã o Rá pida-Ensaio Clínic TREC Collaborative Group to assess this combiCollaborative Group to assess this combination against intramuscular benzodiazenation against intramuscular benzodiazepines. One trial was conducted in Rio de pines. One trial was conducted in Rio de Janeiro (TREC-Rio) and the other in India Janeiro (TREC-Rio) and the other in India (TREC-India). Here we present results of (TREC-India). Here we present results of TREC-India and comment briefly on those TREC-India and comment briefly on those of TREC-Rio. Intramuscular lorazepam is of TREC-Rio. Intramuscular lorazepam is used increasingly to handle psychiatric used increasingly to handle psychiatric emergencies in India, costs the same as the emergencies in India, costs the same as the haloperidol-promethazine combination haloperidol-promethazine combination (£0.17) and offers the advantage of produ-(£0.17) and offers the advantage of producing no dystonic or extrapyramidal adverse cing no dystonic or extrapyramidal adverse effects; however, its efficacy in relation to effects; however, its efficacy in relation to the antipsychotic-antihistamine combinathe antipsychotic-antihistamine combination is unclear. TREC-India was a pragmation is unclear. TREC-India was a pragmatic randomised trial undertaken in realtic randomised trial undertaken in realworld world conditions comparing an intraconditions comparing an intramuscular combination of haloperidol plus muscular combination of haloperidol plus promethazine promethazine v.
v. intramuscular lorazepam. intramuscular lorazepam.
METHOD METHOD Setting Setting
This pragmatic randomised controlled trial, This pragmatic randomised controlled trial, designed to include patients typical of those designed to include patients typical of those presenting to emergency services and to presenting to emergency services and to interfere little with routine practice, was interfere little with routine practice, was conducted in the emergency services of the conducted in the emergency services of the The institutional research and ethics committee approved the trial design, the committee approved the trial design, the consent procedure and the form used. consent procedure and the form used.
Sample size Sample size
From the existing literature, with tranquilliFrom the existing literature, with tranquillisation of 73% of people given benzodiazesation of 73% of people given benzodiazepines and 57% given typical antipsychotics pines and 57% given typical antipsychotics (Battaglia (Battaglia et al et al, 1997; Joy , 1997; Joy et al et al, 2003 Joy et al et al, ), with , 2003 , with a power of 80% at 95% confidence a power of 80% at 95% confidence intervals and an expected precision of intervals and an expected precision of 20%, the minimum sample size required 20%, the minimum sample size required was 90 people per arm. was 90 people per arm.
Randomisation and interventions Randomisation and interventions
Eligible patients were randomised to Eligible patients were randomised to receive either intramuscular haloperidol receive either intramuscular haloperidol (10 mg) and promethazine (25 or 50 mg) (10 mg) and promethazine (25 or 50 mg) mixed in the same syringe, or intramuscular mixed in the same syringe, or intramuscular lorazepam (4 mg). All doses were at the lorazepam (4 mg). All doses were at the discretion of the attending doctor, although discretion of the attending doctor, although the recommended dose was 10 mg halothe recommended dose was 10 mg haloperidol plus 50 mg promethazine, or 4 mg peridol plus 50 mg promethazine, or 4 mg lorazepam. These doses were arrived at by lorazepam. These doses were arrived at by prevailing clinical practice and a pilot study prevailing clinical practice and a pilot study that showed that at least 4 mg lorazepam that showed that at least 4 mg lorazepam was required to achieve a similar degree was required to achieve a similar degree Randomisation was according to a Randomisation was according to a computer-generated random numbers list computer-generated random numbers list in varying sized blocks of less than 10 prein varying sized blocks of less than 10 prepared by the UK collaborator. This pared by the UK collaborator. This collaborator worked with a member of collaborator worked with a member of the TREC-India team who had no clinical the TREC-India team who had no clinical responsibilities in conducting the trial. The responsibilities in conducting the trial. The team member and a pharmacist prepared team member and a pharmacist prepared consecutively numbered opaque cardboard consecutively numbered opaque cardboard boxes, identical in appearance and weight, boxes, identical in appearance and weight, on the outside of which was a form with on the outside of which was a form with questions to be completed by the attending questions to be completed by the attending doctor while 'blind' to the contents of the doctor while 'blind' to the contents of the box. The boxes contained haloperidol box. The boxes contained haloperidol (5 mg (5 mg6 62 ampoules) plus promethazine 2 ampoules) plus promethazine (50 mg (50 mg6 61 ampoule) or lorazepam 1 ampoule) or lorazepam (4 mg (4 mg6 61 ampoule), as determined by the 1 ampoule), as determined by the randomisation list, one disposable syringe randomisation list, one disposable syringe and needle and study follow-up forms. All and needle and study follow-up forms. All those involved clinically in the study had those involved clinically in the study had no indication of what medicines were in no indication of what medicines were in the boxes until they were opened. the boxes until they were opened.
Procedure Procedure
Once eligibility of a patient was ensured, Once eligibility of a patient was ensured, the next consecutive box was taken from the next consecutive box was taken from the emergency cupboard and this constithe emergency cupboard and this constituted randomisation. The duty doctor tuted randomisation. The duty doctor recorded the severity of the episode and recorded the severity of the episode and the initial diagnosis on the form stuck to the initial diagnosis on the form stuck to the outside of the sealed intervention pack. the outside of the sealed intervention pack. The box was then opened and the intervenThe box was then opened and the intervention administered. The patient was then tion administered. The patient was then followed up at 15, 30, 60 and 120 min by followed up at 15, 30, 60 and 120 min by the treatment team and at 240 min and at the treatment team and at 240 min and at 2 weeks by the study coordinators. Data 2 weeks by the study coordinators. Data were also obtained from the case notes as were also obtained from the case notes as well as from interviews with relatives and well as from interviews with relatives and the treatment team. the treatment team.
Blinding Blinding
The study was blind until the point of treatThe study was blind until the point of treatment assignment, which minimised selecment assignment, which minimised selection bias. After assignment, rating for the tion bias. After assignment, rating for the first 2 h was not blind as the management first 2 h was not blind as the management team had to know the prescribed medicateam had to know the prescribed medications. In any event, TREC-India evaluated tions. In any event, TREC-India evaluated real-world interventions that are not given real-world interventions that are not given blind. The study coordinators, however, blind. The study coordinators, however, who were blind to interventions given, who were blind to interventions given, undertook ratings at 240 min. At this time, undertook ratings at 240 min. At this time, they also guessed the allocated intervention, they also guessed the allocated intervention, to assess their blinding. to assess their blinding.
Outcomes Outcomes
Patients were rated at each assessment Patients were rated at each assessment point on whether they were tranquil or point on whether they were tranquil or asleep; in addition, the time of onset of asleep; in addition, the time of onset of tranquillisation and sleep were noted. Partitranquillisation and sleep were noted. Participants were considered to be tranquil cipants were considered to be tranquil when they were calm and not exhibiting when they were calm and not exhibiting agitated, aggressive or dangerous behavagitated, aggressive or dangerous behaviour. They were considered to be asleep if, iour. They were considered to be asleep if, on inspection, they appeared to be sound on inspection, they appeared to be sound asleep and were not aroused by ambient asleep and were not aroused by ambient disturbances; the depth of this apparent disturbances; the depth of this apparent slumber was not assessed further. They slumber was not assessed further. They were also rated on the Clinical Global were also rated on the Clinical Global Impression -Severity (CGI-S) scale at Impression -Severity (CGI-S) scale at entry, and the CGI-Improvement (CGI-I) entry, and the CGI-Improvement (CGI-I) scale (Guy, 1976 ) with respect to aggresscale (Guy, 1976) with respect to aggression and violence, the Simpson-Angus sion and violence, the Simpson-Angus extrapyramidal side-effects rating scale extrapyramidal side-effects rating scale (Simpson & Angus, 1970) and the Barnes (Simpson & Angus, 1970) and the Barnes Akathisia Scale (Barnes, 1989) at each Akathisia Scale (Barnes, 1989) at each assessment point; any other clinically imassessment point; any other clinically important adverse effect, especially dystonia, portant adverse effect, especially dystonia, was also noted. These assessments were was also noted. These assessments were conducted only on participants who were conducted only on participants who were awake, as extrapyramidal symptoms are awake, as extrapyramidal symptoms are usually not apparent during sleep or, in usually not apparent during sleep or, in the case of dystonia or akathisia, are likely the case of dystonia or akathisia, are likely to prevent sleep. Other outcomes within the to prevent sleep. Other outcomes within the first 4 h were the use of additional medifirst 4 h were the use of additional medication for control of agitated or aggressive cation for control of agitated or aggressive behaviour, the use of physical restraints, behaviour, the use of physical restraints, the need for further medical attention and the need for further medical attention and numbers absconding. Participants were also numbers absconding. Participants were also followed up 2 weeks later to check for followed up 2 weeks later to check for adverse effects or adverse outcomes and adverse effects or adverse outcomes and compliance with oral medication. The compliance with oral medication. The primary outcome was 'tranquil or asleep primary outcome was 'tranquil or asleep by 4 h'. by 4 h'.
Data analyses Data analyses
We used double data entry and analysed We used double data entry and analysed data using the Statistical Package for Social data using the Statistical Package for Social Sciences (SPSS) version 9.0 for Windows. Sciences (SPSS) version 9.0 for Windows. We assessed the adequacy of randomisation We assessed the adequacy of randomisation by comparing participants' baseline socioby comparing participants' baseline sociodemographic and clinical characteristics. demographic and clinical characteristics. We compared proportions tranquillised, We compared proportions tranquillised, asleep, improved (CGI much and very asleep, improved (CGI much and very much improved, stipulated in the trial promuch improved, stipulated in the trial protocol), requiring restraints, requiring the tocol), requiring restraints, requiring the doctor to be recalled and requiring addidoctor to be recalled and requiring additional sedation, all using the chi-squared tional sedation, all using the chi-squared test, with a continuity correction, or Fishtest, with a continuity correction, or Fisher's exact test, as appropriate. We caler's exact test, as appropriate. We calculated relative risks and an absolute culated relative risks and an absolute measure, the number-needed-to-treat measure, the number-needed-to-treat (NNT), and their 95% confidence intervals (NNT), and their 95% confidence intervals (Altman, 1998) using intention-to-treat (Altman, 1998) using intention-to-treat analysis. We also used repeated measures analysis. We also used repeated measures analysis of variance to compare mean analysis of variance to compare mean CGI-I scores between groups across var-CGI-I scores between groups across various time points, with being asleep at the ious time points, with being asleep at the follow-up points entered as a covariate. We follow-up points entered as a covariate. We used the Mann-Whitney used the Mann-Whitney U U-test to compare -test to compare mean times to tranquillisation and sedation mean times to tranquillisation and sedation in the two groups, as the data did not have in the two groups, as the data did not have a normal distribution. The kappa statistic a normal distribution. The kappa statistic was used to evaluate agreement between was used to evaluate agreement between the blinded guesses of the coordinators the blinded guesses of the coordinators regarding treatment allocation. regarding treatment allocation.
RESULTS RESULTS
A total of 221 patients presented to the A total of 221 patients presented to the emergency services with disruptive behavemergency services with disruptive behaviour over a 5-month period in 2002. iour over a 5-month period in 2002. Twenty-one people could not be included Twenty-one people could not be included in the trial for reasons outlined in the in the trial for reasons outlined in the CONSORT diagram (Fig. 1) . The remain-CONSORT diagram (Fig. 1) . The remaining 200 patients were randomised. The ing 200 patients were randomised. The follow-up rate for the primary outcome at follow-up rate for the primary outcome at 4 h was 100% for those given lorazepam 4 h was 100% for those given lorazepam and 99% for the antipsychotic-antihistamine and 99% for the antipsychotic-antihistamine combination. Follow-up rates for secondcombination. Follow-up rates for secondary outcomes and at 2 weeks were 92% ary outcomes and at 2 weeks were 92% for those allocated to lorazepam and for those allocated to lorazepam and 90% for people given the antipsychotic-90% for people given the antipsychoticantihistamine combination. antihistamine combination.
All patients allocated to the lorazepam All patients allocated to the lorazepam arm received 4 mg of the drug and everyone arm received 4 mg of the drug and everyone randomised to haloperidol-promethazine randomised to haloperidol-promethazine received 10 mg of haloperidol combined received 10 mg of haloperidol combined with 50 mg (96/100) or 25 mg (4/100) with 50 mg (96/100) or 25 mg (4/100) promethazine. promethazine.
Most patients were male, were diagMost patients were male, were diagnosed to have mania (ICD-10; World nosed to have mania (ICD-10; World Health Organization, 1992) and were rated Health Organization, 1992) and were rated as markedly or severely ill (Table 1) . Nineas markedly or severely ill (Table 1) . Nineteen patients with severe depression with teen patients with severe depression with agitation, psychotic or suicidal behaviour agitation, psychotic or suicidal behaviour were judged to require parenteral mediwere judged to require parenteral medication to prevent harm to themselves or cation to prevent harm to themselves or others. Groups were evenly balanced on others. Groups were evenly balanced on the numbers on psychotropic medication, the numbers on psychotropic medication, mean age and CGI mean scores. mean age and CGI mean scores.
The study coordinators accurately The study coordinators accurately guessed allocation for 58% of those given guessed allocation for 58% of those given lorazepam and 33% of those given the lorazepam and 33% of those given the antipsychotic-antihistamine combination antipsychotic-antihistamine combination ( (k k7 70.68). 0.68).
Equal numbers of people (96%) were Equal numbers of people (96%) were 'tranquil or asleep' by 4 h. The combination 'tranquil or asleep' by 4 h. The combination treatment, however, resulted in more treatment, however, resulted in more people being tranquil/asleep by 15 min, people being tranquil/asleep by 15 min, 30 min, 1 h and 2 h (Table 2) . Haloperidol 30 min, 1 h and 2 h (Table 2) . Haloperidol plus promethazine was also superior to plus promethazine was also superior to lorazepam in inducing sleep. The 40% lorazepam in inducing sleep. The 40% difference in favour of the antipsychoticdifference in favour of the antipsychoticantihistamine mix at 15 min increased to antihistamine mix at 15 min increased to 47% by 30 min but receded to 31% by 47% by 30 min but receded to 31% by 4 h. That the combination treatment 4 h. That the combination treatment produced faster onset of tranquillisation/ produced faster onset of tranquillisation/ sedation was additionally evident when sedation was additionally evident when mean time to onset of tranquillisation/ mean time to onset of tranquillisation/ sleep and mean time to sleep were sleep and mean time to sleep were compared (Table 3) . Four people given compared (Table 3) . Four people given lorazepam were never tranquil, compared lorazepam were never tranquil, compared with one allocated to the haloperidolwith one allocated to the haloperidolpromethazine mix. Twenty-three people promethazine mix. Twenty-three people given lorazepam failed to sleep at all during given lorazepam failed to sleep at all during the 4-h follow-up compared with only eight the 4-h follow-up compared with only eight in the combination group. in the combination group.
The haloperidol-promethazine combiThe haloperidol-promethazine combination also resulted in greater numbers of nation also resulted in greater numbers of people being rated as clinically improved people being rated as clinically improved (Table 2) . Compared with lorazepam, the ( Table 2) . Compared with lorazepam, the 31% difference at 15 min in favour of the 31% difference at 15 min in favour of the antipsychotic-antihistamine combination antipsychotic-antihistamine combination receded to 14% at 2 h. By 4 h there was receded to 14% at 2 h. By 4 h there was no difference in CGI scores between the no difference in CGI scores between the two interventions. two interventions.
The mean scores on the CGI-I scale The mean scores on the CGI-I scale over the 4 h of follow-up were entered into over the 4 h of follow-up were entered into repeat measures analysis of variance (Table  repeat measures analysis of variance (Table  4 ). The CGI scores showed significant dif-4). The CGI scores showed significant differences over time as well as between ferences over time as well as between groups. When being asleep was entered as groups. When being asleep was entered as a covariate to control for differential sedaa covariate to control for differential sedative effects between drugs on clinical imtive effects between drugs on clinical improvement ratings, CGI scores continued provement ratings, CGI scores continued to show differences over time, but the to show differences over time, but the differences in CGI scores between drugs differences in CGI scores between drugs administered was not significant. administered was not significant.
Despite the superiority of the antiDespite the superiority of the antipsychotic-antihistamine combination in psychotic-antihistamine combination in producing sedation, the two interventions producing sedation, the two interventions did not differ in proportions of people did not differ in proportions of people requiring restraint, exhibiting further epirequiring restraint, exhibiting further episodes of agitation or violence and needing sodes of agitation or violence and needing additional medication, or in requiring the additional medication, or in requiring the duty doctor to be recalled (Table 2) , nor duty doctor to be recalled (Table 2) , nor were there differences for the outcomes of were there differences for the outcomes of admitted or discharged after 4 h, and lost admitted or discharged after 4 h, and lost to follow-up over 4 h and 2 weeks. No to follow-up over 4 h and 2 weeks. No differences were evident between interdifferences were evident between interventions in those with different clinical ventions in those with different clinical diagnoses, or with respect to age or gender diagnoses, or with respect to age or gender (data available on request). None of those (data available on request). None of those given the combination reported any adverse given the combination reported any adverse effects, whereas one person given lorazeeffects, whereas one person given lorazepam, who had a history of bronchial pam, who had a history of bronchial asthma, complained of moderate worsening asthma, complained of moderate worsening of respiratory difficulty and another reof respiratory difficulty and another reported nausea and dizziness following the ported nausea and dizziness following the administration of the benzodiazepine. administration of the benzodiazepine. CONSORT diagram forTREC^India. 
DISCUSSION DISCUSSION
It is estimated that approximately 15
It is estimated that approximately 15 million people in India suffer from serious million people in India suffer from serious mental disorders (schizophrenia 2.7/1000, mental disorders (schizophrenia 2.7/1000, affective disorders 12.3/1000 and organic affective disorders 12.3/1000 and organic psychoses 0.4/1000; Reddy & Chandrasepsychoses 0.4/1000; Reddy & Chandrasekhar, 1998). Although systematically ascerkhar, 1998). Although systematically ascertained prevalence data for violence among tained prevalence data for violence among people with psychiatric disorders in lowpeople with psychiatric disorders in lowand middle-income countries are scant, and middle-income countries are scant, there is no evidence to suggest that the there is no evidence to suggest that the prevalence of violent or agitated behaviour prevalence of violent or agitated behaviour is likely to be any less in low-income is likely to be any less in low-income countries such as India than elsewhere. countries such as India than elsewhere. The magnitude of the problem faced by The magnitude of the problem faced by emergency services in India is therefore emergency services in India is therefore readily apparent. readily apparent.
Management of agitation
Management of agitation and violence in emergency and violence in emergency settings: lack of consensus settings: lack of consensus Drugs commonly used to manage agitation Drugs commonly used to manage agitation and violence in emergency situations worldand violence in emergency situations worldwide include antipsychotics, benzodiaze wide include antipsychotics, benzodiazepines pines and antipsychotic and benzodiazepine and antipsychotic and benzodiazepine comcombinations (Allen, 2002; McAllisterbinations (Allen, 2002; McAllisterWilliams & Ferrier, 2002) . More recent Williams & Ferrier, 2002) . More recent strategies include longer-acting drugs strategies include longer-acting drugs such as zuclopenthixol acetate (Coutinho such as zuclopenthixol acetate (Coutinho et al et al, 2000) and rapidly acting intra-, 2000) and rapidly acting intramuscular formulations of the atypical muscular formulations of the atypical antipsychotics olanzapine (Jones antipsychotics olanzapine (Jones et al et al, , 2001 ) and ziprasidone (Brook 2001) and ziprasidone (Brook et al et al, 2000) . , 2000). The recommendations of guidelines for The recommendations of guidelines for the management of psychiatric emergencies the management of psychiatric emergencies (Royal College of Psychiatrists, 1998; (Royal College of Psychiatrists, 1998; Expert Consensus Guideline Group, 1999) Expert Consensus Guideline Group, 1999) are not evidence-based (Allen, 2002) , or are not evidence-based (Allen, 2002 ), or are they followed uniformly (Pilowsky are they followed uniformly (Pilowsky et et al al, 1992; Cunnane, 1994; Binder & , 1992; Cunnane, 1994; Binder & McNeil, 1999; Huf McNeil, 1999; Huf et al et al, 2002 Huf et al et al, , 2002a . Evidence ). Evidence from randomised trials and systematic from randomised trials and systematic reviews is limited and does not indicate reviews is limited and does not indicate the superiority of zuclopenthixol acetate the superiority of zuclopenthixol acetate over conventional antipsychotics (Fenton over conventional antipsychotics (Fenton et al et al, 2003) , or the commonly used combi-, 2003), or the commonly used combination of haloperidol and benzodiazepines nation of haloperidol and benzodiazepines over haloperidol alone (Battaglia over haloperidol alone (Battaglia et al et al, , 1997) . There is a suggestion that benzo-1997). There is a suggestion that benzodiazepines are superior to typical antidiazepines are superior to typical antipsychotics (Battaglia psychotics (Battaglia et al et al, 1997; Allen, , 1997; Allen, 2002) and that haloperidol is superior to 2002) and that haloperidol is superior to placebo (Joy placebo (Joy et al et al, 2003) . , 2003).
Management of violence in middleManagement of violence in middleand low-income countries and low-income countries Group, 2003) randomised 301 people over 6 months to receive either 301 people over 6 months to receive either a haloperidol-promethazine mix or intraa haloperidol-promethazine mix or intramuscular midazolam. Though midazolam muscular midazolam. Though midazolam is available in India, it is five-times as is available in India, it is five-times as expensive as the haloperidol and proexpensive as the haloperidol and promethazine mix and is not in common use methazine mix and is not in common use in psychiatry. in psychiatry.
Midazolam consistently induced more Midazolam consistently induced more rapid tranquillisation and sedation than the rapid tranquillisation and sedation than the haloperidol-promethazine mix. However, haloperidol-promethazine mix. However, the combination treatment in TREC-Rio the combination treatment in TREC-Rio was less tranquillising/sedating than in was less tranquillising/sedating than in TREC-India (Table 5 ). Similar numbers of TREC-India (Table 5) . Similar numbers of people in both trials were male, markedly people in both trials were male, markedly ill and psychotic. In TREC-India, however, ill and psychotic. In TREC-India, however, everyone allocated combination treatment everyone allocated combination treatment re received 10 mg haloperidol. In the TRECceived 10 mg haloperidol. In the TRECRio Rio haloperidol-promethazine arm, 77/148 haloperidol-promethazine arm, 77/148 (52%) were given 5 mg haloperidol and (52%) were given 5 mg haloperidol and 71/148 (48%) were given 10 mg. Most 71/148 (48%) were given 10 mg. Most people allocated to the combination people allocated to the combination treatment in both studies were given treatment in both studies were given 50 mg promethazine. Subgroup analysis of 50 mg promethazine. Subgroup analysis of the two different doses of haloperidol in the two different doses of haloperidol in TREC-Rio, however, did not suggest TREC-Rio, however, did not suggest differences in numbers tranquil/asleep differences in numbers tranquil/asleep (Evandro Coutinho, personal communica-(Evandro Coutinho, personal communication, 2003) . However, evaluation of tion, 2003). However, evaluation of whether the dose of haloperidol matters whether the dose of haloperidol matters will require a direct comparison with an will require a direct comparison with an adequately large sample. adequately large sample.
TREC-India did not compare halo-TREC-India did not compare haloperidol alone with a haloperidol-lorazepam peridol alone with a haloperidol-lorazepam 6 7 6 7 combination, but adding promethazine to combination, but adding promethazine to haloperidol could be superior to adding haloperidol could be superior to adding lorazepam for promoting tranquillisation lorazepam for promoting tranquillisation and sedation and superior to haloperidol and sedation and superior to haloperidol alone for preventing extrapyramidal alone for preventing extrapyramidal adverse effects such as acute dystonia or adverse effects such as acute dystonia or akathisia (Salzman akathisia (Salzman et al et al, 1991; Battaglia , 1991; Battaglia et al et al, 1997; Brook , 1997; Brook et al et al, 2000) . No serious , 2000) . No serious adverse effects, particularly those related adverse effects, particularly those related to the extrapyramidal system, were to the extrapyramidal system, were reported for either treatment, although the reported for either treatment, although the moderate worsening of respiratory diffimoderate worsening of respiratory difficulty reported with lorazepam is in keeping culty reported with lorazepam is in keeping with the known association of benzodiazewith the known association of benzodiazepines with respiratory depression. pines with respiratory depression.
About 15% of people in this trial were About 15% of people in this trial were physically restrained and less than 10% physically restrained and less than 10% were given additional medication over the were given additional medication over the 4 h. This common practice in India and 4 h. This common practice in India and Brazil (Huf Brazil (Huf et al et al, 2002 , 2002a a) of physically ) of physically restraining disruptive patients after adminrestraining disruptive patients after administration of a parenteral drug as opposed istration of a parenteral drug as opposed to administering additional medication to administering additional medication requires evaluation. requires evaluation.
The two treatment regimens evaluated The two treatment regimens evaluated in this study are inexpensive, effective and in this study are inexpensive, effective and available worldwide. Where rapid sedation available worldwide. Where rapid sedation is needed a combination of intramuscular is needed a combination of intramuscular haloperidol and promethazine is superior haloperidol and promethazine is superior to intramuscular lorazepam. to intramuscular lorazepam.
TREC-Rio trial: a randomised controlled trial for rapid TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency tranquillisation for agitated patients in emergency psychiatric rooms [ISRCTN44153243] . psychiatric rooms [ISRCTN44153243] . BMC Psychiatry BMC Psychiatry, , 2 2, 11.
, 11. Pragmatic randomised trials of interventions relevant to low-income countries, with limited funding, clinically meaningful outcomes and low attrition rates, are with limited funding, clinically meaningful outcomes and low attrition rates, are possible within the field of mental health. possible within the field of mental health.
LIMITATIONS LIMITATIONS
& & Assessments over the first 2 h were not blind and were carried out by multiple Assessments over the first 2 h were not blind and were carried out by multiple raters. raters. 
